Aevum program
Aevum Daily Tadalafil Program
PDE5 inhibitor, via Telios
From 39 USD / mo
A daily low-dose tadalafil telehealth program for erectile function, evaluated and prescribed through Telios.
Continue at Telios →Telehealth program. Opening soon.
- Clinician-prescribed via Telios
- Daily low-dose option
- Well-established evidence base
Tadalafil is well-established and well-studied — we route it through Telios so a clinician owns the prescription and the follow-up.
What the evidence says
Tadalafil is an FDA-approved PDE5 inhibitor with extensive randomized-trial evidence for erectile dysfunction and benign prostatic hyperplasia; daily low-dose regimens are well studied.
From the Physiome library
Independent, evidence-tiered reading on the science behind this product.
